What should you know about tofacitinib psoriatic arthritis?

Tofacitinib for psoriatic arthritis is a specialist-prescribed option whose suitability depends on disease activity, previous treatment, other health conditions, and monitoring needs. It modifies immune signalling and may be used to address inflammatory joint symptoms in selected patients. A rheumatologist should weigh potential benefits against alternatives and your personal risks.

Psoriatic arthritis may involve joint pain, joint swelling, morning stiffness, finger or toe swelling, and tendon-area pain. Treatment aims to calm inflammation and protect movement; it does not replace care for skin or eye symptoms when those are present. Before prescribing, tell your clinician about infections, vaccination plans, liver or kidney disease, blood problems, pregnancy plans, and all medicines and supplements. Do not share tablets or change the dose yourself.

Take the medicine exactly as instructed and attend follow-up appointments and any blood tests requested. Report fever, a persistent cough, painful urination, unusual bruising, or marked fatigue. Keep track of swollen joints, stiffness, function, and possible side effects so the review is useful. Physiotherapy, pacing, joint-protection strategies, and prescribed anti-inflammatory medication may form part of a wider plan when appropriate.

Contact your medical team promptly if you develop infection symptoms, severe abdominal pain, unexplained bruising, or a sudden worsening of joint symptoms. Seek urgent help for chest pain, sudden breathlessness, coughing blood, one-sided leg swelling, facial swelling, or trouble breathing.

Ask why this medicine fits your psoriatic arthritis, how joint and skin symptoms will be followed, which tests are needed, what interactions matter, and what action to take during an infection.